Monika Baehner

CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study

Philippe A. Cassier, Antoîne Italiano, Carlos Gomez-Roca et al. · The Lancet Oncology · 2015 · 363 citations

Medicine, Oncology, Pharmacology +14

Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia

Norbert Vey, Jacques Delaunay, Giovanni Martinelli et al. · Oncotarget · 2016 · 99 citations · Full text

Medicine, Hematology, Oncology +15

Phase I study of RG7155, a novel anti-CSF1R antibody, in patients with advanced/metastatic solid tumors.

Carlos Gomez-Roca, Philippe A. Cassier, Antoîne Italiano et al. · Journal of Clinical Oncology · 2015 · 33 citations

Medicine, Oncology, Pharmacology +17

Anti-tumoral, anti-angiogenic and anti-metastatic efficacy of a tetravalent bispecific antibody (TAvi6) targeting VEGF-A and angiopoietin-2

Werner Scheuer, Markus Thomas, Johannes Sam et al. · mAbs · 2016 · 23 citations · Full text

Medicine, Cancer Biology, Oncology +17

Crystal Structure of Human TWEAK in Complex with the Fab Fragment of a Neutralizing Antibody Reveals Insights into Receptor Binding

Alfred Lammens, Monika Baehner, Ulrich Kohnert et al. · PLoS ONE · 2013 · 22 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15